Abstract
Obesity has been recognized as an important risk factor for many serious medical conditions. The association of obesity with an increased risk of many cancers is of enormous economic importance to the health industry.The metabolic syndrome and visceral obesity have an increasing prevelance and incidence in the general population.The actual prevelance of the metabolic syndrome is 24% in US population and between 24.6% and 30.9% in Europe. Recent evidence from epidemiologic and basic research studies, as well as clinical and intervention studies, supports the emerging hypothesis that metabolic syndrome may be an important etiologic factor for the onset of cancer. In addition, increased body weight has recently been shown to be associated with an increased risk of cancers at multiple specific sites. The close interaction between cancer cells and adipocytes is an intriguing issue in tumor biology. In nowdays, several metabolic markers are implicated in the development and progression of several malignancies. This review describes the emerging data concerning the role of metabolic markes in tumor cell growth and relates them to their future clinical prospects.
Keywords: Metabolic syndrome, insulin-like growth factors, leptin, adiponectin, ghrelin, carcinogenesis, Obesity, cancer, hyperinsulinemia, Insulin, cardiovascular disease, adipokines, interleukin-6, tumor necrosis factor-α, apoptosis, EDTA, Adipose tissue, diabetes, body mass index, colorectal cancer, benign prostatic hyperplasia, breast cancer, Angiogenesis, diabetic retinopathy, benign prostatic hypertrophy, testosterone, estradiol, dihydrotestosterone, dehydroepiandrosterone sulfate, colonocyte cell proliferation, human hepatoma cells, Cancer Anorexia, anorexia, chronic obstructive pulmonary disease, Cachexia
Anti-Cancer Agents in Medicinal Chemistry
Title: Obesity Modulation - The Role in Carcinogenesis
Volume: 10 Issue: 6
Author(s): Ioannis Legakis and Kostantinos Syrigos
Affiliation:
Keywords: Metabolic syndrome, insulin-like growth factors, leptin, adiponectin, ghrelin, carcinogenesis, Obesity, cancer, hyperinsulinemia, Insulin, cardiovascular disease, adipokines, interleukin-6, tumor necrosis factor-α, apoptosis, EDTA, Adipose tissue, diabetes, body mass index, colorectal cancer, benign prostatic hyperplasia, breast cancer, Angiogenesis, diabetic retinopathy, benign prostatic hypertrophy, testosterone, estradiol, dihydrotestosterone, dehydroepiandrosterone sulfate, colonocyte cell proliferation, human hepatoma cells, Cancer Anorexia, anorexia, chronic obstructive pulmonary disease, Cachexia
Abstract: Obesity has been recognized as an important risk factor for many serious medical conditions. The association of obesity with an increased risk of many cancers is of enormous economic importance to the health industry.The metabolic syndrome and visceral obesity have an increasing prevelance and incidence in the general population.The actual prevelance of the metabolic syndrome is 24% in US population and between 24.6% and 30.9% in Europe. Recent evidence from epidemiologic and basic research studies, as well as clinical and intervention studies, supports the emerging hypothesis that metabolic syndrome may be an important etiologic factor for the onset of cancer. In addition, increased body weight has recently been shown to be associated with an increased risk of cancers at multiple specific sites. The close interaction between cancer cells and adipocytes is an intriguing issue in tumor biology. In nowdays, several metabolic markers are implicated in the development and progression of several malignancies. This review describes the emerging data concerning the role of metabolic markes in tumor cell growth and relates them to their future clinical prospects.
Export Options
About this article
Cite this article as:
Legakis Ioannis and Syrigos Kostantinos, Obesity Modulation - The Role in Carcinogenesis, Anti-Cancer Agents in Medicinal Chemistry 2010; 10 (6) . https://dx.doi.org/10.2174/1871520611009060481
DOI https://dx.doi.org/10.2174/1871520611009060481 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
Call for Papers in Thematic Issues
Induction of cell death in cancer cells by modulating telomerase activity using small molecule drugs
Telomeres are distinctive but short stretches present at the corners of chromosomes and aid in stabilizing chromosomal makeup. Resynthesis of telomeres supported by the activity of reverse transcriptase ribonucleoprotein complex telomerase. There is no any telomerase activity in human somatic cells, but the stem cells and germ cells undergone telomerase ...read more
Role of natural compounds as anti anti-cancer agents
Cancer is considered the leading cause of worldwide mortality, accounting for nearly 10 million deaths in 2022. Cancer outcome can be improved through an appropriate screening and early detection and through an efficient clinical treatment. Chemotherapy remains an important approach in treatment o f several types of cancers, even though ...read more
Signaling and enzymatic modulators in cancer treatment
Cancer accounts for nearly 10 million deaths in 2022 and is considered the leading cause of worldwide mortality. Cancer outcome can be improved through an appropriate screening and early detection and through an efficient clinical treatment. Chemotherapy, radiotherapy and surgery are the most important approach for the treatment of several ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Sodium Selenite Decreased HDAC Activity, Cell Proliferation and Induced Apoptosis in Three Human Glioblastoma Cells
Anti-Cancer Agents in Medicinal Chemistry Effect of Administration Route on the Biodistribution and Shedding of Replication-Deficient AAV2: A Qualitative Modelling Approach
Current Gene Therapy A Review of the Chemical and Pharmacological Aspects of the Genus Marrubium
Current Pharmaceutical Design Multifunctionalized Microbubbles for Cancer Diagnosis and Therapy
Anti-Cancer Agents in Medicinal Chemistry Inhibiting Cyclin-Dependent Kinase / Cyclin Activity for the Treatment of Cancer and Cardiovascular Disease
Current Pharmaceutical Biotechnology Advances in Drug Delivery from Nose to Brain: An Overview
Current Drug Therapy Minimally Invasive Transoral Surgical Treatment for Oropharyngeal Carcinoma
Current Cancer Therapy Reviews Telomerase Inhibition in Cancer Therapeutics: Molecular-Based Approaches
Current Medicinal Chemistry Potential Prophylactic and Therapeutic Vaccines for HSV Infections
Current Pharmaceutical Design Artepillin C Induces Selective Oxidative Stress and Inhibits Migration and Invasion in a Comprehensive Panel of Human Cervical Cancer Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Non-viral Delivery Systems for the Application in p53 Cancer Gene Therapy
Current Medicinal Chemistry Recent Methods for Assessing Bone Mineral Density, Bone Strength, Fracture Risk and Therapeutic Effects on Osteoporosis
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Human Defensins: Synthesis and Structural Properties
Current Pharmaceutical Design High Throughput Screening of Normal and Neoplastic Tissue Samples
Combinatorial Chemistry & High Throughput Screening Voltage-Gated Sodium Channel Blockers as Immunomodulators
Recent Patents on CNS Drug Discovery (Discontinued) Fundamentals of Nanocarriers and Probiotics in the Treatment of Cervical Cancer
Current Nanomedicine Diarylurea: A Privileged Scaffold in Drug Discovery and Therapeutic Development
Current Medicinal Chemistry Mechanism of Action of Flavonoids in Prevention of Inflammation- Associated Skin Cancer
Current Medicinal Chemistry Design, Synthesis, and Evaluation of Genistein Analogues as Anti-Cancer Agents
Anti-Cancer Agents in Medicinal Chemistry Tumor-Induced Alterations in Lipid Metabolism
Current Medicinal Chemistry